31. März 2026
Fähzan Ahmad • 31. März 2026
Why experimental convenience often comes at the cost of real-world relevance

Immortalized cell lines are widely used in in vitro research due to their stability, scalability, and ease of handling. They enable reproducible experiments under controlled conditions. However, this convenience often comes at the cost of biological relevance.
Regulatory evaluation depends on how well a model reflects real biology—not how easily it can be used.
The limitation of cell lines
Cell lines undergo genetic and phenotypic changes over time. Adaptation to artificial culture conditions can alter signaling pathways, receptor expression, and metabolic behavior.
As a result, responses observed in these systems may not reflect those of primary cells or in vivo environments.
Why this matters for interpretation
Effects detected in cell lines may be reproducible—but still misleading. A compound may appear active due to model-specific artifacts rather than true biological interaction.
Without validation in more relevant systems, conclusions remain uncertain.
Regulatory perspective
Regulators expect evidence generated in models that are biologically meaningful. This often requires confirmation in primary cells or systems that better represent the target tissue or mechanism.
Data derived solely from simplified models is typically considered limited in predictive value.
Conclusion
A model that is easy to use is not necessarily the right model.
Cell lines enable experiments.
Biological relevance determines their value.








